Citations (32)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Daniel L. Drane, Kelsey C. Hewitt, Michele E. Price, Beth K. Rush, Karen Blackmon, Noah Okada, Taylor Shade, Edward Valentin, Joseph Vinson, Phyllis Rosen & David W. Loring. (2023) Case study of invalid to valid shift in cognitive performance following successful treatment of psychogenic nonepileptic seizure events. Journal of Clinical and Experimental Neuropsychology 45:10, pages 1024-1038.
Read now
Read now
Michael M. Copenhaver, Victoria Sanborn, Roman Shrestha, Colleen Mistler & John Gunstad. (2021) Association between the brief inventory of neurocognitive impairment (BINI) and objective cognitive testing among persons with opioid use disorders in drug treatment. Journal of Addictive Diseases 39:2, pages 166-174.
Read now
Read now
Maren
Cecilie Strand, Bente Fjeld, Marianne Arnestad & Jørg Mørland. (2013) Can Patients Receiving Opioid Maintenance Therapy Safely Drive? A Systematic Review of Epidemiological and Experimental Studies on Driving Ability With a Focus on Concomitant Methadone or Buprenorphine Administration. Traffic Injury Prevention 14:1, pages 26-38.
Read now
Read now
Michael Soyka, Claudia Limmer, Robert Lehnert, Gabriele Koller, Gabriele Martin, Heinrich Küfner, S. Kagerer & Annina Haberthür. (2011) A Comparison of Cognitive Function in Patients under Maintenance Treatment with Heroin, Methadone, or Buprenorphine and Healthy Controls: An Open Pilot Study. The American Journal of Drug and Alcohol Abuse 37:6, pages 497-508.
Read now
Read now
Michael Soyka, Henry R. Kranzler, Wim van den Brink, John Krystal, Hans-Jürgen Möller & Siegfried Kasper. (2011) The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Substance Use and Related Disorders. Part 2: Opioid dependence. The World Journal of Biological Psychiatry 12:3, pages 160-187.
Read now
Read now
Allison
J. Applebaum, Michael
W. Otto, Mark
A. Richardson & Steven
A. Safren. (2010) Contributors to neuropsychological impairment in HIV-infected and HIV-uninfected opiate-dependent patients. Journal of Clinical and Experimental Neuropsychology 32:6, pages 579-589.
Read now
Read now
Articles from other publishers (26)
Irene Pericot-Valverde, Kaileigh A. Byrne, Erik G. Ortiz, Stephanie Davis, Ethan Hammond, Shadi Nahvi, James F. Thrasher, Laksika B. Sivaraj, Sam Cumby, Eli Goodwin, Ashley C. King, Julia Arnsten, Sergio Fernández-Artamendi, Moonseong Heo & Alain H. Litwin. (2023) Preliminary Evidence of the Association between Time on Buprenorphine and Cognitive Performance among Individuals with Opioid Use Disorder Maintained on Buprenorphine: A Pilot Study. International Journal of Environmental Research and Public Health 20:16, pages 6610.
Crossref
Crossref
Abhishek Ghosh, Alka Shaktan, Abhishek Verma, Ritu Nehra, Debasish Basu, Devender K Rana, Chirag K Ahuja, Manish Modi & Paramjit Singh. (2023) Neurocognitive Functions in Opioid Dependence: Comparisons Between Opioid Categories. Journal of Drug Issues, pages 002204262311792.
Crossref
Crossref
Monica Rivera Mindt, Kelly Coulehan, Maral Aghvinian, Travis M. Scott, James Patrick Olsen, Chinazo O. Cunningham, Franchesca Arias & Julia H. Arnsten. (2022) Underrepresentation of diverse populations and clinical characterization in opioid agonist treatment research: A systematic review of the neurocognitive effects of buprenorphine and methadone treatment. Journal of Substance Abuse Treatment 135, pages 108644.
Crossref
Crossref
Xintong Cai, Jianbo Zhang, Yunxiao Li, Cuola Deji, Jinting Zhou & Shengbin Li. (2022) Several nAChRs gene variants are associated with phenotypes of heroin addiction in Chinese Han population. Neuroscience Letters 774, pages 136532.
Crossref
Crossref
Nazanin Sadeghamal Nikraftar, Yasha Fayaz Feyzi, Fatemeh Ramzani, Marjan Nikbakht-Zadeh, Mahdi Amini, Mohammad Arezoomandan, Maryam Shiehmorteza & Reza Arezoomandan. (2021) Comparison of psychological symptoms and cognitive functions in patients under maintenance treatment with methadone or buprenorphine, current opioid users and healthy subjects. Asian Journal of Psychiatry 58, pages 102603.
Crossref
Crossref
Rajoo Saroj, Abhishek Ghosh, BN Subodh, Ritu Nehra, Tathagata Mahintamani, Devender K. Rana & Debasish Basu. (2020) Neurocognitive functions in patients on buprenorphine maintenance for opioid dependence: A comparative study with three matched control groups. Asian Journal of Psychiatry 53, pages 102181.
Crossref
Crossref
Caroline A. Browne, Moriah L. Jacobson & Irwin Lucki. (2020) Novel Targets to Treat Depression: Opioid-Based Therapeutics. Harvard Review of Psychiatry 28:1, pages 40-59.
Crossref
Crossref
Aniella Murphy, John Barbaro, Pablo Martínez-Aguado, Vanessa Chilunda, Matias Jaureguiberry-Bravo & Joan W. Berman. (2019) The Effects of Opioids on HIV Neuropathogenesis. Frontiers in Immunology 10.
Crossref
Crossref
A. Baldacchino, S. Tolomeo, D.J. Balfour & K Matthews. (2018) Profiles of visuospatial memory dysfunction in opioid-exposed and dependent populations. Psychological Medicine 49:07, pages 1174-1184.
Crossref
Crossref
Kevin Butler & Bernard Le Foll. (2019) Impact of Substance Use Disorder Pharmacotherapy on Executive Function: A Narrative Review. Frontiers in Psychiatry 10.
Crossref
Crossref
Elise E. DeVito, Hedy Kober, Kathleen M. Carroll & Marc N. Potenza. (2019) fMRI Stroop and behavioral treatment for cocaine-dependence: Preliminary findings in methadone-maintained individuals. Addictive Behaviors 89, pages 10-14.
Crossref
Crossref
Sabine Kagerer-Volk. 2019. Suchtmedizin. Suchtmedizin
385
396
.
Camille Noélie Pujol, Cecilia Paasche, Vincent Laprevote, Benoit Trojak, Pierre Vidailhet, Elisabeth Bacon & Laurence Lalanne. (2018) Cognitive effects of labeled addictolytic medications. Progress in Neuro-Psychopharmacology and Biological Psychiatry 81, pages 306-332.
Crossref
Crossref
Moriah L. Jacobson, Hildegard A. Wulf, Caroline A. Browne & Irwin Lucki. 2018. The Opioid System as the Interface between the Brain’s Cognitive and Motivational Systems. The Opioid System as the Interface between the Brain’s Cognitive and Motivational Systems
1
48
.
Michael Copenhaver, Roman Shrestha, Jeffrey A. Wickersham, Damian Weikum & Frederick L. Altice. (2016) An Exploratory Factor Analysis of a Brief Self-Report Scale to Detect Neurocognitive Impairment Among Participants Enrolled in Methadone Maintenance Therapy. Journal of Substance Abuse Treatment 63, pages 61-65.
Crossref
Crossref
A. Baldacchino, D. J. K. Balfour & K. Matthews. (2014) Impulsivity and opioid drugs: differential effects of heroin, methadone and prescribed analgesic medication. Psychological Medicine 45:6, pages 1167-1179.
Crossref
Crossref
Grace Y Wang, Trecia A Wouldes, Rob Kydd, Maree Jensen & Bruce R Russell. (2014) Neuropsychological performance of methadone-maintained opiate users. Journal of Psychopharmacology 28:8, pages 789-799.
Crossref
Crossref
M. Soyka, S. Dittert, S. Kagerer-Volk & M. Soyka. (2014) Fahrtauglichkeit bei Abhängigkeitserkrankungen und SchizophrenieDriving ability with alcohol and drug dependence and schizophrenia. Der Nervenarzt 85:7, pages 816-821.
Crossref
Crossref
Shane Darke, Skye McDonald, Sharlene Kaye & Michelle Torok. (2012) Comparative patterns of cognitive performance amongst opioid maintenance patients, abstinent opioid users and non-opioid users. Drug and Alcohol Dependence 126:3, pages 309-315.
Crossref
Crossref
B.K. Bracken, G.H. Trksak, D.M. Penetar, W.L. Tartarini, M.A. Maywalt, C.M. Dorsey & S.E. Lukas. (2012) Response inhibition and psychomotor speed during methadone maintenance: impact of treatment duration, dose, and sleep deprivation. Drug and Alcohol Dependence 125:1-2, pages 132-139.
Crossref
Crossref
Warren K. Bickel, David P. Jarmolowicz, E. Terry Mueller, Kirstin M. Gatchalian & Samuel M. McClure. (2012) Are executive function and impulsivity antipodes? A conceptual reconstruction with special reference to addiction. Psychopharmacology 221:3, pages 361-387.
Crossref
Crossref
Kate Driscoll Malliarakis, Valerie Smith & Nancy Darbro. (2012) Regulatory Management of Substance Use in High-Risk Nurse Populations. Journal of Nursing Regulation 2:4, pages 32-39.
Crossref
Crossref
Pekka Rapeli, Carola Fabritius, Hely Kalska & Hannu Alho. (2011) Cognitive functioning in opioid-dependent patients treated with buprenorphine, methadone, and other psychoactive medications: stability and correlates. BMC Clinical Pharmacology 11:1.
Crossref
Crossref
Teresa R. Gray, Riet Dams, Robin E. Choo, Hendree E. Jones & Marilyn A. Huestis. (2011) Methadone disposition in oral fluid during pharmacotherapy for opioid-dependence. Forensic Science International 206:1-3, pages 98-102.
Crossref
Crossref
Pekka Rapeli, Carola Fabritius, Hely Kalska & Hannu Alho. (2009) Memory function in opioid-dependent patients treated with methadone or buprenorphine along with benzodiazepine: longitudinal change in comparison to healthy individuals. Substance Abuse Treatment, Prevention, and Policy 4:1.
Crossref
Crossref
Richard J. Bodnar. (2009) Endogenous opiates and behavior: 2008. Peptides 30:12, pages 2432-2479.
Crossref
Crossref